Safety and Occupational Health Study Section: Notice of Charter Renewal, 42455 [2010-17759]
Download as PDF
Federal Register / Vol. 75, No. 139 / Wednesday, July 21, 2010 / Notices
or her records or otherwise provide
enough information to enable the
identification of the individual’s record;
(3) identify the information that the
individual believes is not accurate,
relevant, timely or complete; (4)
indicate what corrective action is
sought; and (5) include supporting
justification or documentation for the
requested amendment. Verification of
identity as described in the
Department’s Privacy Act regulations
may be required. 45 CFR 5b.5.
RECORD SOURCE CATEGORIES:
Information is obtained from
individuals and organizations,
including third parties conducting
business on behalf of a business or
organization, that apply for access
privileges to the FPLS Child Support
Services Portal and its services.
Prevention, Department of Health and
Human Services, has been renewed for
a 2-year period through June 30, 2012.
FOR FURTHER INFORMATION CONTACT:
Price Connor, PhD, Executive Secretary,
Safety and Occupational Health Study
Section, Department of Health and
Human Services, 1600 Clifton Road,
NE., Mailstop E74, Atlanta, Georgia
30333, telephone 404/498–2511 or fax
404/498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
EXEMPTIONS CLAIMED FOR THE SYSTEM:
None.
[FR Doc. 2010–17738 Filed 7–20–10; 8:45 am]
[FR Doc. 2010–17759 Filed 7–20–10; 8:45 am]
BILLING CODE 4184–42–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
Safety and Occupational Health Study
Section: Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Safety
and Occupational Health Study Section,
Centers for Disease Control and
[Docket No. FDA–2010–N–0318]
Novartis Pharmaceuticals Corp. et al.;
Withdrawal of Approval of 27 New
Drug Applications and 58 Abbreviated
New Drug Applications
AGENCY:
ACTION:
42455
Notice.
The Food and Drug
Administration (FDA) is withdrawing
approval of 27 new drug applications
(NDAs) and 58 abbreviated new drug
applications (ANDAs) from multiple
applicants. The holders of the
applications notified the agency in
writing that the drug products were no
longer marketed and requested that the
approval of the applications be
withdrawn.
SUMMARY:
DATES:
Effective Date: August 20, 2010.
FOR FURTHER INFORMATION CONTACT:
Florine P. Purdie, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 6366,
Silver Spring, MD 20993–0002, 301–
796–3601.
The
holders of the applications listed in
table 1 of this document have informed
FDA that these drug products are no
longer marketed and have requested that
FDA withdraw approval of the
applications pursuant to the process in
§ 314.150(c) (21 CFR 314.150(c)). The
applicants have also, by their requests,
waived their opportunity for a hearing.
Withdrawal of approval of an
application or abbreviated application
under § 314.150(c) is without prejudice
to refiling.
SUPPLEMENTARY INFORMATION:
Food and Drug Administration,
HHS.
TABLE 1.
Application No.
Drug
Applicant
Mesantoin (mephenytoin) Tablets
Novartis Pharmaceuticals Corp., One Health Plaza, East Hanover, NJ
07936–1080
NDA 9–000
Cafergot (ergotamine tartrate and caffeine) Suppository, 1 milligram (mg)/100 mg and 2 mg/100 mg
Do.
NDA 9–561
Hypaque (diatrizoate sodium)
GE Healthcare, Inc., 101 Carnegie Center, Princeton, NJ 08540
NDA 9–658
Hydrocortisone Tablets
Smith, Miller and Patch, Inc., Division of Cooper Vision, Inc., c/o Cooper Laboratories, Inc., 455 E. Middlefied Rd., Mountain View, CA
94043
NDA 9–942
Deltra (prednisone) Tablets
Merck & Co., Inc., P.O. Box 4, BLA–20, West Point, PA 19486–0004
NDA 10–051
erowe on DSKG8SOYB1PROD with NOTICES
NDA 6–008
Hydeltra (prednisolone) Tablets
Do.
NDA 10–255
Meticortelone (prednisolone acetate) Injection and
Suspension
Schering Corp., Galloping Hill Rd., Kenilworth, NJ 07033
NDA 12–885
Winstrol (stanozolol) Tablets, 2 mg
Lundbeck, Inc., Four Parkway North, Deerfield, IL 60015
NDA 13–428
Valpin (anisotropine methylbromide) Tablets
Endo Pharmaceuticals, 100 Endo Blvd., Chadds Ford, PA 19317
VerDate Mar<15>2010
15:19 Jul 20, 2010
Jkt 220001
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
E:\FR\FM\21JYN1.SGM
21JYN1
Agencies
[Federal Register Volume 75, Number 139 (Wednesday, July 21, 2010)]
[Notices]
[Page 42455]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17759]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section: Notice of Charter
Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Safety and Occupational Health
Study Section, Centers for Disease Control and Prevention, Department
of Health and Human Services, has been renewed for a 2-year period
through June 30, 2012.
FOR FURTHER INFORMATION CONTACT: Price Connor, PhD, Executive
Secretary, Safety and Occupational Health Study Section, Department of
Health and Human Services, 1600 Clifton Road, NE., Mailstop E74,
Atlanta, Georgia 30333, telephone 404/498-2511 or fax 404/498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-17759 Filed 7-20-10; 8:45 am]
BILLING CODE 4163-18-P